Download PDF
Semin intervent Radiol 2017; 34(02): 182-186
DOI: 10.1055/s-0037-1601853
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interventional Oncology Service Development

Samdeep Mouli
1   Department of Radiology and Radiologic Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
,
Jennifer C. Baker
1   Department of Radiology and Radiologic Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
,
Daniel B. Brown
1   Department of Radiology and Radiologic Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
› Author Affiliations
Further Information

Publication History

Publication Date:
01 June 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Interventional oncology is rapidly expanding its suite of oncologic therapies, providing unique proven therapeutic benefits. To grow a practice alongside other oncology specialties, knowledge of cancer fundamentals is required. Areas of interest include methods to assess disease stage, treatment toxicity, and response. Additionally, techniques to leverage opportunities and resources available at one's institution toward practice development and efficiency will be reviewed.

Keywords

interventional radiology - chemoembolization - radioembolization - radiofrequency ablation - practice development
 

  • References

  • 1 Hickey R, Vouche M, Sze DY. , et al. Cancer concepts and principles: primer for the interventional oncologist-part II. J Vasc Interv Radiol 2013; 24 (08) 1167-1188
    CrossrefPubMedGoogle Scholar
  • 2 Llovet JM, Real MI, Montaña X. , et al; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359 (9319): 1734-1739
    CrossrefPubMedGoogle Scholar
  • 3 Lo C-M, Ngan H, Tso WK. , et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35 (05) 1164-1171
    CrossrefPubMedGoogle Scholar
  • 4 Benson III AB, D'Angelica MI, Abrams TA. , et al. Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw 2014; 12 (08) 1152-1182
    CrossrefPubMedGoogle Scholar
  • 5 Kulke MH, Shah MH, Benson III AB. , et al; National comprehensive cancer network. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw 2015; 13 (01) 78-108
    CrossrefPubMedGoogle Scholar
  • 6 Motzer RJ, Jonasch E, Agarwal N. , et al; National comprehensive cancer network. Kidney cancer, version 3.2015. J Natl Compr Canc Netw 2015; 13 (02) 151-159
    CrossrefPubMedGoogle Scholar
  • 7 American Journal of Clinical Oncology. Available at: https://cancerstaging.org/CSE/Physician/Pages/Articles.aspx . Accessed November 2016
    PubMed
  • 8 Network and Computing Consultants. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp . Accessed November 2016
    PubMed
  • 9 National Institutes of Health, National Cancer Institute. Available at: https://www.cancer.gov/publications/pdq . Accessed November 2016
    PubMed
  • 10 Riaz A, Memon K, Miller FH. , et al. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol 2011; 54 (04) 695-704
    CrossrefPubMedGoogle Scholar
  • 11 Hickey R, Vouche M, Sze DY. , et al. Cancer concepts and principles: primer for the interventional oncologist-part I. J Vasc Interv Radiol 2013; 24 (08) 1157-1164
    CrossrefPubMedGoogle Scholar
  • 12 Bergmann L, Berns B, Dalgleish AG. , et al; Biotherapy Development Association. Investigator-initiated trials of targeted oncology agents: why independent research is at risk?. Ann Oncol 2010; 21 (08) 1573-1578
    CrossrefPubMedGoogle Scholar
  • 13 Pazdur R. Endpoints for assessing drug activity in clinical trials. Oncologist 2008; 13 (Suppl. 02) 19-21
    CrossrefPubMedGoogle Scholar
  • 14 National Cancer Institute. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm . Accessed November 2016
    PubMed
  • 15 DeVita Jr VT, Canellos GP. Hematology in 2010: new therapies and standard of care in oncology. Nat Rev Clin Oncol 2011; 8 (02) 67-68
    CrossrefPubMedGoogle Scholar
  • 16 Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol 1994; 10 (01) 12-20
    CrossrefPubMedGoogle Scholar
  • 17 Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230 (03) 309-318 , discussion 318–321
    CrossrefPubMedGoogle Scholar
  • 18 Pawlik TM, Scoggins CR, Zorzi D. , et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241 (05) 715-722 , discussion 722–724
    CrossrefPubMedGoogle Scholar
  • 19 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
    CrossrefPubMedGoogle Scholar
  • 20 Ahmed M. ; Technology Assessment Committee of the Society of Interventional Radiology. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol 2014; 25 (11) 1706-1708
    CrossrefPubMedGoogle Scholar
  • 21 Ahmed M, Solbiati L, Brace CL. , et al; International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. J Vasc Interv Radiol 2014; 25 (11) 1691-705.e4
    CrossrefPubMedGoogle Scholar
  • 22 Giaccia A, Weinstein R, Hu J, Stamato TD. Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell. Somat Cell Mol Genet 1985; 11 (05) 485-491
    CrossrefPubMedGoogle Scholar
  • 23 Halperin EC. The promise of innovation in radiation oncology?. Lancet Oncol 2013; 14 (09) 802-804
    CrossrefPubMedGoogle Scholar
  • 24 Halperin EC, Perez CA, Brady LW. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008
    Google Scholar
  • 25 Shewach DS, Lawrence TS. Radiosensitization of human solid tumor cell lines with gemcitabine. Semin Oncol 1996; 23 (5, Suppl 10): 65-71
    PubMedGoogle Scholar
  • 26 Lawrence TS, Davis MA, Tang HY, Maybaum J. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression. Int J Radiat Biol 1996; 70 (03) 273-280
    CrossrefPubMedGoogle Scholar
  • 27 Crane CH, Wolff RA, Abbruzzese JL. , et al. Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. Semin Oncol 2001; 28 (3, Suppl 10): 25-33
    CrossrefPubMedGoogle Scholar
  • 28 Wilson GD, Bentzen SM, Harari PM. Biologic basis for combining drugs with radiation. Semin Radiat Oncol 2006; 16 (01) 2-9
    CrossrefPubMedGoogle Scholar
  • 29 Siskin G. Outpatient care of the interventional radiology patient. Semin Intervent Radiol 2006; 23 (04) 337-345
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 White Jr RI, Denny Jr DF, Osterman FA, Greenwood LH, Wilkinson LA. Logistics of a university interventional radiology practice. Radiology 1989; 170 (3 Pt 2): 951-954
    CrossrefPubMedGoogle Scholar
  • 31 Pentecost MJ, Criqui MH, Dorros G. , et al; Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, American Heart Association. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 2003; 14 (9 Pt 2): S495-S515
    CrossrefPubMedGoogle Scholar
  • 32 Brown DB, Gould JE. Practice building in interventional oncology. Tech Vasc Interv Radiol 2006; 9 (03) 90-95
    CrossrefPubMedGoogle Scholar
  • 33 Siskin GP, Bagla S, Sansivero GE, Mitchell NL. The interventional radiology clinic: what you need to know. Semin Intervent Radiol 2005; 22 (01) 39-44
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Siskin GP, Bagla S, Sansivero GE, Mitchell NL. The interventional radiology clinic: key ingredients for success. J Vasc Interv Radiol 2004; 15 (07) 681-688
    CrossrefPubMedGoogle Scholar
  • 35 Abboud S, Partovi S, Nakamoto D, Azar N. The radiologist will see you now: patients' perceptions of an outpatient interventional clinic. Curr Probl Diagn Radiol 2016; 45 (02) 137-138
    CrossrefPubMedGoogle Scholar
  • 36 Lutjeboer J, Burgmans MC, Chung K, van Erkel AR. Impact on Patient Safety and Satisfaction of Implementation of an Outpatient Clinic in Interventional Radiology (IPSIPOLI-Study): a quasi-experimental prospective study. Cardiovasc Intervent Radiol 2015; 38 (03) 543-551
    CrossrefPubMedGoogle Scholar
  • 37 Koran ME, Lipnik AJ, Baker JC, Banovac F, Omary RA, Brown DB. Procedural impact of a dedicated interventional oncology service line in a national cancer institute comprehensive cancer center. J Am Coll Radiol 2016; 13 (09) 1145-1150
    CrossrefPubMedGoogle Scholar
  • 38 Chrisman HB, Basu PA, Omary RA. The positive effect of targeted marketing on an existing uterine fibroid embolization practice. J Vasc Interv Radiol 2006; 17 (03) 577-581
    CrossrefPubMedGoogle Scholar
  • 39 Ventola CL. Social media and health care professionals: benefits, risks, and best practices. P&T 2014; 39 (07) 491-520
    PubMedGoogle Scholar
  • 40 Hamm MP, Chisholm A, Shulhan J. , et al. Social media use by health care professionals and trainees: a scoping review. Acad Med 2013; 88 (09) 1376-1383
    CrossrefPubMedGoogle Scholar
  • 41 Prasad B. Social media, health care, and social networking. Gastrointest Endosc 2013; 77 (03) 492-495
    CrossrefPubMedGoogle Scholar
  • 42 Househ M. The use of social media in healthcare: organizational, clinical, and patient perspectives. Stud Health Technol Inform 2013; 183: 244-248
    PubMedGoogle Scholar
  • 43 Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res 2013; 15 (04) e85
    CrossrefPubMedGoogle Scholar